Competitor Name | Times Picked |
SGLT2i Without DM | 705 |
K Binders in CKD | 454 |
Patient-Driven Choice for Dialysis | 328 |
Biomarkers in Rejection | 282 |
Percutaneous AVF Creation | 236 |
Climate Change and CKD | 213 |
End-of-Life care for Patients on Dialysis | 202 |
Flu Vaccine | 196 |
Consumable Waste in HD | 141 |
Biopsy in Rejection | 114 |
Policy-Driven Outcomes for Dialysis | 112 |
K is Good in CKD | 97 |
Marijuana OK | 94 |
SGLT2i in Transplant | 93 |
Exercise Prevents HyperK | 80 |
Disposable Waste in HD | 78 |
Climate Change and AKI | 78 |
Pneumonia Vaccine | 61 |
American Guidelines | 61 |
Live Vaccines in Transplant | 57 |
TG Feedback | 55 |
Genetic Counseling for Cystic Diseases | 48 |
EU Guidelines | 46 |
Dialysis for Patients at End-of-Life | 38 |
Non-TG Feedback | 37 |
Women with X-linked Alport | 34 |
Surgical AVFCreation | 32 |
No Live Vaccines in Transplant | 24 |
Autosomal Dominant Alport | 23 |
Genetic Counseling for Stones | 23 |
Marijuana Not OK | 18 |
Exercise Causes HyperK | 12 |